Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/3/2025

Management of Vitamin D Deficiency

Understanding Vitamin D Deficiency

  • A vitamin D level of 17 ng/mL is considered deficient, as most guidelines define deficiency as levels below 20 ng/mL (or 50 nmol/L) 1, 2
  • Severe deficiency is typically defined as levels below 10-12 ng/mL (25-30 nmol/L), which significantly increases risk for osteomalacia and nutritional rickets 1
  • Conversion: 25(OH)D: 1 ng/mL = 2.5 nmol/L 1

Treatment Protocol for Vitamin D Deficiency (17 ng/mL)

  • Prescribe ergocalciferol (vitamin D2) 50,000 IU once weekly for 8 weeks 3, 4
  • This loading dose is necessary as standard doses within recommended daily allowance take many weeks to normalize low vitamin D levels 1
  • After completing the loading phase, transition to maintenance therapy of 1,500-2,000 IU daily 2

Monitoring Recommendations

  • Measure follow-up vitamin D level after 3-6 months of therapy to ensure adequate response 1
  • Target serum level should be at least 30 ng/mL (75 nmol/L) for optimal health benefits 2
  • If levels remain insufficient, dose adjustments may be necessary 1

Special Considerations

  • Vitamin D supplementation has minimal risk of toxicity at recommended doses; toxicity typically occurs at levels >200 ng/mL, well above therapeutic targets 5, 6
  • Ergocalciferol (D2) and cholecalciferol (D3) are both effective, though some evidence suggests D3 may maintain levels more effectively long-term 2

Potential Benefits of Treatment

  • Prevention of secondary hyperparathyroidism 3, 4
  • Possible benefits for immune function, though evidence for non-skeletal outcomes is less established 7, 8

Potential Pitfalls

  • Inflammation can reduce plasma vitamin D levels, complicating interpretation of results 1
  • Individual response to supplementation varies due to genetic factors, weight, and other variables 1
  • Avoid calcium co-supplementation if concerned about kidney stone risk 6